Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: A Gynecologic Oncology Group study

Journal of Clinical Oncology

Volumn 20, Issue 7, 2002, Pages 1832-1837

  Bloss, Jeffrey D ^a   Blessing, John A ^a   Behrens, Brent C ^a   Mannel, Robert S ^a   Rader, Janet S ^a   Sood, Anil K ^a   Markman, Maurie ^a   Benda, Jo ^a  

^a Gynecol Oncol Grp Admin Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; IFOSFAMIDE; MESNA;

ADULT; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INFUSION; DRUG RESPONSE; FEMALE; HISTOLOGY; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; NAUSEA; NEUTROPENIA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THROMBOCYTOPENIA; UTERINE CERVIX CARCINOMA; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IFOSFAMIDE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0036534291     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.07.045     Document Type: Article

References (31)

1. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
2. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
3. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
4. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study
5. Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: Report of a phase III Inter-Group Study
6. Chemotherapy of gynecologic cancer
7. Single agent chemotherapy in carcinoma of the cervix
8. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
9. A phase II study of ifosfamide, carboplatin and cisplatin in advanced and recurrent squamous cell carcinoma of the uterine cervix
10. Phase II study of carboplatin/ifosfamide in untreated advanced cervical cancer
11. Cisplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix
12. A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix
13. A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
14. Bleomycin-ifosfamide-cisplatinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: A second look
15. Combined chemotherapy using cisplatin ifosfamide and bleomycin (PIB) in the treatment of advanced and recurrent cervical carcinoma
16. Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer
17. Phase II trial of bleomycin, ifosfamide, and carboplatin in metastatic cervical cancer
18. Design, analysis and interpretation of chemotherapy trials in gynecologic oncology
19. Regression model and life tables
20. The logic of inductive inference
21. Paclitaxel has moderate activity in squamous cervix cancer: A Gynecologic Oncology Group Study
22. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: A Gynecologic Oncology Group
23. A randomized phase III study of cisplatin versus cisplatin plus paclitaxel in stage 1VB, recurrent or persistent squamous cell carcinoma of the cervix
24. North Central Cancer Treatment Group (NCCTG) study of neoadjuvant methotrexate, vincristine, adriamycin, cisplatin (MVCA) in locally advanced cervical carcinoma
25. A Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix
26. Neoadjuvant MVAC (methotrexate, vinblastine, doxorubicin, cisplatin) chemotherapy for locally advanced or metastatic cervical and vaginal cancer
27. Phase II open label multicentric trial of MVAC: Methotrexate (M), vinblastine (V), doxorubicin (D) and cisplatin (C) plus granulocyte colony simulating factor (Filgrastim) in advanced recurrent cervical carcinoma final report
28. Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina
29. A phase II trial of topotecan in patients with advanced squamous cell carcinoma of the cervix